While hepatic fibrosis is attenuated in Fgf15-deficient mice in murine MASH and CCl4-induced models22, administration of an FGF21 analog attenuates hepatic inflammation and fibrosis in a murine MASH model23. Here, FGF21 is linked to metabolic dysfunction-associated steatohepatitis.